{"org_id": "01000908", "org_name_cn": "湖南景峰医药股份有限公司", "org_short_name_cn": "景峰医药", "org_name_en": "Hunan Jingfeng Pharmaceutical Co.,Ltd.", "org_short_name_en": "Jingfeng Pharmaceutical", "main_operation_business": "医药产品的研发、制造与销售。", "operating_scope": "　　以自有资产进行医药、医疗项目投资；生物制药技术项目的研发与投资；商品进出口贸易；企业管理咨询、医疗医药研发技术咨询。（依法须经批准的项目，经相关部门批准后方可开展经营活动）。", "district_encode": "430626", "org_cn_introduction": "湖南景峰医药股份有限公司的主营业务为医药产品的研发、制造与销售。公司的主要产品为注射剂、固体制剂、原料药。公司荣获“医药产业标杆企业”、“2019年度中国大健康产业新锐企业奖”、“2019年度中国社会责任新锐企业”、“2019中国上市药企化学药综合实力排行榜第46名”、“2019年度中国医药工业百强系列排行榜—中药企业TOP100排行榜”，“2020年度中国大健康产业中国药品研发综合实力排行榜第67位”等荣誉称号。", "legal_representative": "叶湘武", "general_manager": "叶湘武", "secretary": "毕元", "established_date": 913910400000, "reg_asset": 879774351.0, "staff_num": 2220, "telephone": "86-21-66876520", "postcode": "201908", "fax": "86-21-66876520", "email": "ir@jfzhiyao.com", "org_website": "www.jfyiyao.com", "reg_address_cn": "湖南省岳阳市平江县天岳开发区天岳大道48号", "reg_address_en": "", "office_address_cn": "上海市宝山区罗店镇罗新路50号", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 917971200000, "provincial_name": "湖南省", "actual_controller": "叶湘武 (14.79%)", "classi_name": "民营企业", "pre_name_cn": "湖南天一科技股份有限公司", "chairman": "叶湘武", "executives_nums": 11, "actual_issue_vol": 45000000.0, "issue_price": 5.79, "actual_rc_net_amt": 249120000.0, "pe_after_issuing": 17.8, "online_success_rate_of_issue": 0.3916, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}